Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1967 1
1968 2
1972 1
1986 1
1988 1
1990 2
1991 2
1992 3
1993 2
1995 3
1996 2
1997 3
1998 4
1999 3
2000 5
2001 7
2002 5
2003 3
2004 4
2005 7
2006 7
2007 6
2008 7
2009 1
2010 7
2011 6
2012 7
2013 9
2014 11
2015 16
2016 19
2017 15
2018 13
2019 16
2020 24
2021 27
2022 21
2023 34
2024 20
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

315 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S. Tawbi HA, et al. Among authors: reed dr. Lancet Oncol. 2017 Nov;18(11):1493-1501. doi: 10.1016/S1470-2045(17)30624-1. Epub 2017 Oct 4. Lancet Oncol. 2017. PMID: 28988646 Free PMC article. Clinical Trial.
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Mulder RL, Font-Gonzalez A, Hudson MM, van Santen HM, Loeffen EAH, Burns KC, Quinn GP, van Dulmen-den Broeder E, Byrne J, Haupt R, Wallace WH, van den Heuvel-Eibrink MM, Anazodo A, Anderson RA, Barnbrock A, Beck JD, Bos AME, Demeestere I, Denzer C, Di Iorgi N, Hoefgen HR, Kebudi R, Lambalk C, Langer T, Meacham LR, Rodriguez-Wallberg K, Stern C, Stutz-Grunder E, van Dorp W, Veening M, Veldkamp S, van der Meulen E, Constine LS, Kenney LB, van de Wetering MD, Kremer LCM, Levine J, Tissing WJE; PanCareLIFE Consortium. Mulder RL, et al. Lancet Oncol. 2021 Feb;22(2):e45-e56. doi: 10.1016/S1470-2045(20)30594-5. Lancet Oncol. 2021. PMID: 33539753 Review.
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.
DuBois SG, Krailo MD, Glade-Bender J, Buxton A, Laack N, Randall RL, Chen HX, Seibel NL, Boron M, Terezakis S, Hill-Kayser C, Hayes A, Reid JM, Teot L, Rakheja D, Womer R, Arndt C, Lessnick SL, Crompton BD, Kolb EA, Daldrup-Link H, Eutsler E, Reed DR, Janeway KA, Gorlick RG. DuBois SG, et al. Among authors: reed dr. J Clin Oncol. 2023 Apr 10;41(11):2098-2107. doi: 10.1200/JCO.22.01815. Epub 2023 Jan 20. J Clin Oncol. 2023. PMID: 36669140 Free PMC article. Clinical Trial.
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.
Cash T, Krailo MD, Buxton AB, Pawel BR, Healey JH, Binitie O, Marcus KJ, Grier HE, Grohar PJ, Reed DR, Weiss AR, Gorlick R, Janeway KA, DuBois SG, Womer RB. Cash T, et al. Among authors: reed dr. J Clin Oncol. 2023 Oct 20;41(30):4724-4728. doi: 10.1200/JCO.23.00053. Epub 2023 Aug 31. J Clin Oncol. 2023. PMID: 37651654 Free PMC article. Clinical Trial.
MrgprA3 neurons drive cutaneous immunity against helminths through selective control of myeloid-derived IL-33.
Inclan-Rico JM, Napuri CM, Lin C, Hung LY, Ferguson AA, Liu X, Wu Q, Pastore CF, Stephenson A, Femoe UM, Musaigwa F, Rossi HL, Freedman BD, Reed DR, Macháček T, Horák P, Abdus-Saboor I, Luo W, Herbert DR. Inclan-Rico JM, et al. Among authors: reed dr. Nat Immunol. 2024 Nov;25(11):2068-2084. doi: 10.1038/s41590-024-01982-y. Epub 2024 Oct 1. Nat Immunol. 2024. PMID: 39354200 Free PMC article.
Children's Oncology Group's 2023 blueprint for research: Bone tumors.
Reed DR, Grohar P, Rubin E, Binitie O, Krailo M, Davis J, DuBois SG, Janeway KA. Reed DR, et al. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30583. doi: 10.1002/pbc.30583. Epub 2023 Jul 27. Pediatr Blood Cancer. 2023. PMID: 37501549 Free PMC article.
Targeting Apoptosis in ALL.
Smith WM, Reed DR. Smith WM, et al. Among authors: reed dr. Curr Hematol Malig Rep. 2022 Apr;17(2):53-60. doi: 10.1007/s11899-022-00661-9. Epub 2022 May 11. Curr Hematol Malig Rep. 2022. PMID: 35538391 Review.
Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes.
Soupir A, Ospina OE, Hampton O, Churchman M, Radmacher M, Hedges D, McKean D, Agius P, Zeeshan S, Seligson ND, Pollock R, Liebner D, Chen JL, Tinoco G, Salhia B, McCarter M, Wilky BA, Miller BJ, Cavnar MJ, Groundland JS, Schneider BP, Riedlinger G, Edge SB, Moskaluk CA, Cardona K, Naqash AR, Gonzalez RJ, Mullinax JE, Joyce DM, Binitie O, Douglas Letson G, Naghavi AO, Druta M, Reed DR, Siegel EM, Teer JK, Fridley BL, Brohl AS. Soupir A, et al. Among authors: reed dr. Nat Commun. 2025 May 6;16(1):4206. doi: 10.1038/s41467-025-58678-6. Nat Commun. 2025. PMID: 40328759 Free PMC article.
Genetics of taste receptors.
Bachmanov AA, Bosak NP, Lin C, Matsumoto I, Ohmoto M, Reed DR, Nelson TM. Bachmanov AA, et al. Among authors: reed dr. Curr Pharm Des. 2014;20(16):2669-83. doi: 10.2174/13816128113199990566. Curr Pharm Des. 2014. PMID: 23886383 Free PMC article. Review.
315 results